<DOC>
	<DOCNO>NCT03026998</DOCNO>
	<brief_summary>The purpose study assess benefit MR screen asymptomatic head &amp; neck ( CNS ) second primary cancer occur hereditary retinoblastoma patient previously treat external beam radiation therapy ( EBRT ) .</brief_summary>
	<brief_title>MRI Screening Second Primary Cancer Occurring Within Radiation Fields After Treatment External Beam Radiation Therapy Hereditary Retinoblastoma ( DepiSCARRH )</brief_title>
	<detailed_description>Patients hereditary retinoblastoma treat infancy external beam radiation therapy ( EBRT ) risk second primary cancer occur within radiation field high . The aim study depict MRI secondary tumor early possible , occurrence clinical symptom . Affected patient manage national expert center dedicate diagnostic treatment procedure . However , benefit management assessed term prognosis .</detailed_description>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>Personal history hereditary retinoblastoma ( i.e. , familial history retinoblastoma , bilateral retinoblastoma , unilateral multifocal retinoblastoma , identify germline RB1 mutation 13q deletion ) External beam radiation therapy ( EBRT ) use retinoblastoma treatment Age inclusion 7 30 year Time period end EBRT inclusion date 5 year Written inform consent sign patient ( legal representative ) Personal history nonfamilial unilateral unifocal retinoblastoma without RB1 germline mutation . Personal history second primary neoplasm occur within radiation field Contraindication MRI ( pacemaker , intraocular metallic foreign body , defibrillator implant electronic device , intracranial ferromagnetic clip ) associate condition prevent MR examination ( intraocular prosthesis implant contraindication MRI ; orthodontic metallic device contraindication might decrease image quality remove , possible ) Patients unable comply followup study requirement , geographical , social psychological reason</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>hereditary retinoblastoma ,</keyword>
	<keyword>External beam radiation therapy ( EBRT )</keyword>
</DOC>